🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of this study is to evaluate and compare the efficacy and sa...
Status
Completed
Location
Buddhist Tzu Chi General Hospital
Start Date
2014-05
Trial ID
NCT02135341
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of NT 2...
Status
Completed
Location
Merz Investigational Site
Start Date
2020-09-23
Trial ID
NCT04594213
The aim of the study is to test the hypothesis that oral taking of baclofen...
Status
Unknown
Location
SBPSU
Start Date
2022-12-01
Trial ID
NCT05617118
Treatments Being Tested
The study objective was to investigate the safety and efficacy of incobotul...
Status
Completed
Location
Skin Care Centre
Start Date
2007-06-18
Trial ID
NCT00512135
Treatments Being Tested
The study objective was to show the superior efficacy of Incobotulinumtoxin...
Status
Completed
Location
Skin Care Center
Start Date
2008-10
Trial ID
NCT00770029
Treatments Being Tested
The aim of this study is to assess the efficacy and safety of BoNT/A-DP in ...
Status
Completed
Location
Total Skin And Beauty Dermatology Center, Pc
Start Date
2016-03-02
Trial ID
NCT02677298
Treatments Being Tested
IncobotulinumtoxinA (Xeomin) is a botulinum toxin type A preparation free o...
Status
Completed
Location
Merz Pharmaceuticals GmbH
Start Date
2006-10
Trial ID
NCT00430963
Treatments Being Tested
Study Type: This is a multicenter, triple-blind, randomized controlled tria...
Status
Recruiting
Location
Faceland
Start Date
2026-02-02
Trial ID
NCT06448676
Treatments Being Tested
The goal of this split-face clinical trial is to test the efficacy of micro...
Status
Completed
Location
K. Kay Durairaj, MD, A Medical Corp.
Start Date
2024-09-03
Trial ID
NCT06604832
Treatments Being Tested
NT 201 is a botulinum toxin type A preparation free of complexing proteins,...
Status
Completed
Location
Merz Pharmaceuticals GmbH
Start Date
2006-11
Trial ID
NCT00430586
Treatments Being Tested